An enhanced packaging system for helper-dependent herpes simplex virus vectors

被引:145
作者
Stavropoulos, TA
Strathdee, CA
机构
[1] John P Robarts Res Inst, Gene Therapy & Mol Virol Grp, London, ON N6A 5K8, Canada
[2] Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada
关键词
D O I
10.1128/JVI.72.9.7137-7143.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Helper-dependent herpes simplex virus (HSV vectors (amplicons) show considerable promise to provide for long term transduced-gene expression in most cell types. The current packaging system of choice for these vectors involves cotransfection with a set of five overlapping cosmids that encode the full HSV type 1 (HSV-1) helper virus genome from which the packaging (pac) elements have been deleted. Although both the helper virus and the HSV amplicon can replicate, only the latter is packaged into infectious viral particles. Since the titers obtained are too low for practical application, an enhanced second-generation packaging system was developed by modifying both the helper virus and the HSV amplicon vector. The helper virus was reverse engineered by using the original five cosmids to generate a single HSV-bacterial artificial chromosome (BAC) clone in Escherichia coli from which the pac elements were deleted to generate a replication-proficient but packaging-defective HSV-1 genome. The HSV amplicon was modified to contain the simian virus 40 origin of replication, which acts as an HSV-independent replicon to provide for the replicative expansion of the vector. The HSV amplicon is packaged into infectious particles by cotransfection with the HSV-BAC helper virus into the 293T cell line, and the resulting cell lysate is free of detectable helper virus contamination. The combination of both modifications to the original packaging system affords an eightfold increase in the packaged-vector yield.
引用
收藏
页码:7137 / 7143
页数:7
相关论文
共 44 条
  • [11] HO DY, 1995, J NEUROCHEM, V65, P842
  • [12] HO DY, 1994, METHOD CELL BIOL, V43, P191
  • [13] HUARD J, 1995, GENE THER, V2, P385
  • [14] JOHNSON K, 1992, J WOMENS HEALTH, V1, P95
  • [15] IMPROVED CELL-SURVIVAL BY THE REDUCTION OF IMMEDIATE-EARLY GENE-EXPRESSION IN REPLICATION-DEFECTIVE MUTANTS OF HERPES-SIMPLEX VIRUS TYPE-1 BUT NOT BY MUTATION OF THE VIRION HOST SHUTOFF FUNCTION
    JOHNSON, PA
    WANG, MJ
    FRIEDMANN, T
    [J]. JOURNAL OF VIROLOGY, 1994, 68 (10) : 6347 - 6362
  • [16] CYTOTOXICITY OF A REPLICATION-DEFECTIVE MUTANT OF HERPES-SIMPLEX VIRUS TYPE-1
    JOHNSON, PA
    MIYANOHARA, A
    LEVINE, F
    CAHILL, T
    FRIEDMANN, T
    [J]. JOURNAL OF VIROLOGY, 1992, 66 (05) : 2952 - 2965
  • [17] Rapid method for construction of recombinant HSV gene transfer vectors
    Krisky, DM
    Marconi, PC
    Oligino, T
    Rouse, RJD
    Fink, DJ
    Glorioso, JC
    [J]. GENE THERAPY, 1997, 4 (10) : 1120 - 1125
  • [18] Utilization of the herpes simplex virus type 1 latency-associated regulatory region to drive stable reporter gene expression in the nervous system
    Lachmann, RH
    Efstathiou, S
    [J]. JOURNAL OF VIROLOGY, 1997, 71 (04) : 3197 - 3207
  • [19] GENE DELIVERY TO NEURONS - IS HERPES-SIMPLEX VIRUS THE RIGHT TOOL FOR THE JOB
    LEIB, DA
    OLIVO, PD
    [J]. BIOESSAYS, 1993, 15 (08) : 547 - 554
  • [20] Lim F, 1996, BIOTECHNIQUES, V20, P460